Post-kala-azar dermal leishmaniasis (PKDL) is a common complication of visceral
leishmaniasis (VL) caused by Leishmania donovani. Because of its possible role in …

Post‐kala‐azar dermal leishmaniasis (PKDL) is a dermal sequela of visceral leishmaniasis
(VL), reported mainly from two regions–Sudan in eastern Africa and the Indian subcontinent …

In Sudan, post kala‐azar dermal leishmaniasis (PKDL) caused by Leishmania donovani
develops in half of the patients treated for visceral leishmaniasis (kala‐azar). In most …

In an exploration of the natural history of post-kala-azar dermal leishmaniasis (PKDL), 134
residents of Sudan who had recently been diagnosed as cases of the disease were …

Post kala-azar dermal leishmaniasis (PKDL), a cutaneous sequela of visceral leishmaniasis
(VL), develops in some patients alongside but more commonly after apparent cure from VL …

Background The South-East Asia Region Kala-azar Elimination Programme (KAEP) is
expected to enter the consolidation phase in 2017, which focuses on case detection, vector …

SUMMARY PKDL develops in about 50% of Sudanese patients treated for visceral
leishmaniasis (kala-azar). Patients with kala-azar were entered into this study and followed …

Introduction Post-kala-azar dermal leishmaniasis (PKDL) is a cutaneous complication
appearing after treatment of visceral leishmaniasis, and PKDL patients are considered …

Background. Post-kala-azar dermal leishmaniasis (PKDL), an established sequela of
visceral leishmaniasis (VL), is proposed to facilitate anthroponotic transmission of VL …

A substantial number of patients who recover from kala‐azar will develop dermatosis
[commonly known as post‐kala‐azar dermal leishmaniasis (PKDL)]. It usually occurs in the …